News
Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what ...
The Johnson & Johnson spinoff that makes Tylenol and Benadryl, said Chief Executive Thibaut Mongon has departed and that the ...
Kenvue appoints Kirk Perry as interim CEO after Thibaut Mongon's exit and launches strategic review to simplify operations.
Kenvue says that CEO Thibaut Mongon is departing as the maker of Listerine and Band-Aid brands continues with a strategic ...
7don MSN
Kenvue, the Johnson & Johnson spinoff that owns brands such as Tylenol and Benadryl, announced Monday that Chief Executive ...
Kenvue’s board of directors are considering ‘a broad range of potential alternatives’ and are hunting for a permanent ...
7don MSN
All that culminated on Monday with the abrupt resignation of Kenvue CEO Thibaut Mongon, his replacement by board director ...
“The Board’s strategic review is underway, and we are considering a broad range of potential alternatives, including ways to ...
Kenvue (KVUE), the company behind Tylenol and Neutrogena, announced that Thibaut Mongon had left the company, naming Kirk ...
7d
Barchart on MSNTylenol-Maker Kenvue Launches Turnaround Plans. How Should You Play KVUE Stock Here?Kenvue Inc ousted its chief executive and announced a strategic review on Monday. Jefferies says KVUE shares could rally to ...
Kenvue, formerly part of Johnson & Johnson, announces CEO Thibaut Mongon's departure as it undergoes a strategic review.
Kenvue CEO Thibaut Mongon has stepped down as the company’s chief executive and departed its board of directors. The CEO of Tylenol maker Kenvue ( KVUE) has left the company as part of an internal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results